Top-News
Quelle: - pixabay.com:
Aufrufe: 91
Eurofins Scientific SE: Director/PDMR Shareholding
This notification is made in accordance with the European Market Abuse Regulation.
| NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM | |||
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Analytical Bioventures S.C.A (RCS B89265) | |
| 2. | Reason for the notification | ||
| a) | Position / status | Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin | |
| b) | Initial notification / amendment | Initial | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Eurofins Scientific S.E. |
|
| b) | LEI | 529900JEHFM47DYY3S57 |
|
| 4. | Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share | |
|
| Identification code | ISIN: FR0014000MR3 | |
| b) | Nature of the transaction | Acquisition of shares |
|
|
| |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| EUR 58.827700 | 2000 | ||
| d) | Aggregated information |
| |
| — Aggregated volume | 2000 | ||
| — Price | EUR 117,655.40 | ||
| e) | Date of the transaction | 2025-06-10 | |
| f) | Place of the transaction | XPAR | |
| NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM | |||
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Analytical Bioventures S.C.A (RCS B89265) | |
| 2. | Reason for the notification | ||
| a) | Position / status | Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin | |
| b) | Initial notification / amendment | Initial | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Eurofins Scientific S.E. |
|
| b) | LEI | 529900JEHFM47DYY3S57 |
|
| 4. | Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share | |
|
| Identification code | ISIN: FR0014000MR3 | |
| b) | Nature of the transaction | Acquisition of shares |
|
|
| |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| EUR 59.275300 | 2000 | ||
| d) | Aggregated information |
| |
| — Aggregated volume | 2000 | ||
| — Price | EUR 118,550.60 | ||
| e) | Date of the transaction | 2025-06-11 | |
| f) | Place of the transaction | XPAR | |
| NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM | |||
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Analytical Bioventures S.C.A (RCS B89265) | |
| 2. | Reason for the notification | ||
| a) | Position / status | Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin | |
| b) | Initial notification / amendment | Initial | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Eurofins Scientific S.E. |
|
| b) | LEI | 529900JEHFM47DYY3S57 |
|
| 4. | Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Share | |
|
| Identification code | ISIN: FR0014000MR3 | |
| b) | Nature of the transaction | Acquisition of shares |
|
|
| |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| EUR 59.711300 | 810 | ||
| d) | Aggregated information |
| |
| — Aggregated volume | 810 | ||
| — Price | EUR 48,366.15 | ||
| e) | Date of the transaction | 2025-06-12 | |
| f) | Place of the transaction | XPAR | |
For more information, please visit www.eurofins.com.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250613167992/en/
Für dich aus unserer Redaktion zusammengestellt
Dein Kommentar zum Artikel im Forum
Jetzt anmelden und diskutieren
Registrieren
Login
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
